Eshbal Reports 2025 Results with Revenue Growth and Margin Improvement

• Earnings Release: Eshbal reported 2025 full-year revenues of US $13.8 million, a 20% year-on-year increase from 2024.
• Profitability Metrics: Gross margin improved to 25.4% in 2025 compared to 22.7% in 2024. However, the company reported an operating loss of $0.3 million for 2025, a reversal from the operating income of $0.6 million in 2024.
• Net Loss Drivers: The net loss of $2.9 million was primarily driven by one-time listing expenses related to its April 2025 reverse takeover (RTO).
• Acquisition Integration: Revenue growth reflects the integration of acquired U.S. brands, specifically Dare to be Different Foods and Gluten Free Nation, which closed in mid-February 2026.
• Side Letter Agreement: A side letter with Starcall Broadcasting LLC regarding Gluten Free Nation assets stipulates cash payments in lieu of share issuances if milestones cause Starcall to hold 10% or more of voting securities.

• Revenue vs. Expectations: The full-year revenue growth confirms the trajectory set by the Q1 2026 estimate ($5.3M estimated, +41% YoY). The 20% full-year growth validates the roll-up strategy's ability to drive top-line expansion despite integration costs.
• Margin Improvement: Gross margin expansion from 22.7% to 25.4% is a positive fundamental indicator of pricing power or cost efficiencies, supporting the "better-for-you" positioning.
• Operating Performance Concern: The flip from operating income ($0.6M) in 2024 to an operating loss ($0.3M) in 2025 is a material negative signal regarding core operational efficiency, even if net loss is attributed largely to one-time RTO expenses.
• Market Reaction Context: The news follows the Q1 2026 revenue estimate released on April 6, 2026. As this confirms previous guidance rather than surprising the market with new data, it falls under routine earnings reporting.
• Overall Impact: While top-line metrics are strong, the deterioration in operating income suggests the cost of growth (RTO expenses + integration) is currently outpacing operational efficiency gains. The stock price impact is likely muted as this was anticipated following the RTO and acquisition announcements.

• Core Business: Eshbal Functional Food Inc. operates in the gluten-free and "better-for-you" food category with over 300 SKUs.
• Flagship Product: Gluten-free pita bread is a key product line, now transitioning to local North American production via Queen Street Bakery partnership.
• Strategy: The company is executing an aggressive roll-up strategy in the artisanal gluten-free market, acquiring U.S.-based brands (Dare to be Different Foods, Gluten Free Nation) to secure distribution channels like Walmart and Target.
• Operations: Dual presence with Israeli manufacturing capabilities and expanding North American production/distribution infrastructure.